The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy

di Ma, Honghai, Zhang, Tiehong, Shen, Hongchang, Cao, Hongxin, Du, Jiajun
Pubblicazione 2014

Lower Blood Calcium Associates with Unfavorable Prognosis and Predicts for Bone Metastasis in NSCLC

di Shen, Hongchang, Li, Yongqiu, Liao, Yida, Zhang, Tiehong, Liu, Qi, Du, Jiajun
Pubblicazione 2012

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma

di Zhang, Tiehong, Shen, Hongchang, Dong, Wei, Qu, Xiao, Liu, Qi, Du, Jiajun
Pubblicazione 2014

Evaluation of Preoperative Hematologic Markers as Prognostic Factors and Establishment of Novel Risk Stratification in Resected pN0 Non-Small-Cell Lung Cancer

di Zhang, Tiehong, Jiang, Yuanzhu, Qu, Xiao, Shen, Hongchang, Liu, Qi, Du, Jiajun
Pubblicazione 2014

Tumor-stroma ratio is an independent predictor for survival in NSCLC

di Zhang, Tiehong, Xu, Jun, Shen, Hongchang, Dong, Wei, Ni, Yang, Du, Jiajun
Pubblicato in Int J Clin Exp Pathol (2015)

Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes

di Liu, Hongfeng, Yan, Tao, Zhang, Tiehong, Chen, Xiaowei, Wang, Yadong, Du, Jiajun
Pubblicato in Medicine (Baltimore) (2019)

The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer

di Yang, Miaomiao, Cao, Hongxin, Guo, Xi, Zhang, Tiehong, Hu, Pingping, Du, Jiajun, Liu, Qi
Pubblicazione 2013

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort

di Sun, Haifeng, Hu, Pingping, Shen, Hongchang, Dong, Wei, Zhang, Tiehong, Liu, Qi, Du, Jiajun
Pubblicato in PLoS One (2015)

Predictive Effects of Lung function test on Postoperative Pneumonia in Squamous Esophageal Cancer

di Wei, Ran, Dong, Wei, Shen, Hongchang, Ni, Yang, Zhang, Tiehong, Wang, Yibing, Du, Jiajun
Pubblicato in Sci Rep (2016)

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies

di Zhu, Linhai, Cao, Hongxin, Zhang, Tiehong, Shen, Hongchang, Dong, Wei, Wang, Liguang, Du, Jiajun
Pubblicato in Medicine (Baltimore) (2016)

Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis

di Shen, Hongchang, Che, Keying, Cong, Lei, Dong, Wei, Zhang, Tiehong, Liu, Qi, Du, Jiajun
Pubblicato in Oncotarget (2017)

Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis

di Qu, Xiao, Wang, Kai, Zhang, Tiehong, Shen, Hongchang, Dong, Wei, Liu, Qi, Du, Jiajun
Pubblicato in J Thorac Dis (2017)

Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients

di Zhao, Yang, Shen, Hongchang, Qiu, Chen, Zhang, Tiehong, Hu, Pingping, Qu, Xiao, Liu, Qi, Du, Jiajun
Pubblicato in Medicine (Baltimore) (2015)

Prognostic significance of tumor budding and single cell invasion in gastric adenocarcinoma

di Che, Keying, Zhao, Yang, Qu, Xiao, Pang, Zhaofei, Ni, Yang, Zhang, Tiehong, Du, Jiajun, Shen, Hongchang
Pubblicato in Onco Targets Ther (2017)

Prognostic effects of preoperative obstructive pneumonitis or atelectasis and comparison with tumor size in non-small cell lung cancer

di Pang, Zhaofei, Ding, Nan, Dong, Wei, Ni, Yang, Zhang, Tiehong, Qu, Xiao, Du, Jiajun, Liu, Qi
Pubblicato in J Thorac Dis (2017)

Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy

di Qu, Xiao, Wu, Zhinan, Dong, Wei, Zhang, Tiehong, Wang, Liguang, Pang, Zhaofei, Ma, Wei, Du, Jiajun
Pubblicato in Oncotarget (2017)

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma

di Li, Xiaowei, Che, Keying, Wang, Liguang, Zhang, Tiehong, Wang, Guanghui, Pang, Zhaofei, Shen, Hongchang, Du, Jiajun
Pubblicato in Medicine (Baltimore) (2017)

Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis

di Pang, Zhaofei, Yang, Yufan, Ding, Nan, Huang, Cuicui, Zhang, Tiehong, Ni, Yang, Du, Jiajun, Liu, Qi
Pubblicato in J Thorac Dis (2017)

Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer

di Jiang, Wensheng, Wang, Liguang, Zhang, Jiangang, Shen, Hongchang, Dong, Wei, Zhang, Tiehong, Li, Xiaowei, Wang, Kai, Du, Jiajun
Pubblicato in Medicine (Baltimore) (2018)

ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response

di Shen, Hongchang, Wang, Liguang, Zhang, Jiangang, Dong, Wei, Zhang, Tiehong, Ni, Yang, Cao, Hongxin, Wang, Kai, Li, Yun, Wang, Yibing, Du, Jiajun
Pubblicato in Oncol Rep (2017)